Disclosed are compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and one or more excipients, wherein at least one of the excipients modifies release of amantadine. Methods of administering the same are also provided.

Edits on 28 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 28 Sep, 2023

Edits made to:

Infobox (+2 properties)

Infobox

Patent Inventor Names

Gregory T. Went0

Timothy J. Fultz0

Edits on 22 Jul, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 22 Jul, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=09072697

Edits on 23 May, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 23 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 09072697 Composition and method for treating neurological disease US Patent 9072697 Composition and method for treating neurological disease

Infobox

Patent Number

09072697

Patent Number

9072697

Edits on 8 Jun, 2022

"Entity importer update"

Golden AI

edited on 8 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=09072697

Edits on 2 Jan, 2022

"Created via: Entity Importer"

Golden AI

created this topic on 2 Jan, 2022

Edits made to:

Infobox (+9 properties)

‌

US Patent 09072697 Composition and method for treating neurological disease

Infobox

Is a

Patent

Patent applicant

Current assignee

Patent jurisdiction

United States Patent and Trademark Office

Patent number

09072697

Date of patent

July 7, 2015

Patent application number

14591641

Date Filed

January 7, 2015

Patent primary examiner

‌

Paul Zarek

Find more entities like US Patent 9072697 Composition and method for treating neurological disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.